share_log

Avenue Therapeutics | CORRESP: CORRESP

Avenue Therapeutics | CORRESP: CORRESP

Avenue Therapeutics | CORRESP:信函
美股sec公告 ·  05/08 12:46
Moomoo AI 已提取核心信息
Avenue Therapeutics, Inc. has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company, based in Bay Harbor Islands, Florida, submitted the request via EDGAR on May 8, 2024, with the desired effective date being 4:00 p.m. Eastern time on May 10, 2024, or as soon as possible thereafter. The request was made under Rule 461 of the Securities Act of 1933, as amended. Avenue Therapeutics has authorized Rakesh Gopalan and David S. Wolpa, attorneys from its outside legal counsel Troutman Pepper Hamilton Sanders LLP, to modify or withdraw the acceleration request if necessary. The company has asked the SEC to confirm the Registration Statement's effective status with its legal representatives upon approval.
Avenue Therapeutics, Inc. has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company, based in Bay Harbor Islands, Florida, submitted the request via EDGAR on May 8, 2024, with the desired effective date being 4:00 p.m. Eastern time on May 10, 2024, or as soon as possible thereafter. The request was made under Rule 461 of the Securities Act of 1933, as amended. Avenue Therapeutics has authorized Rakesh Gopalan and David S. Wolpa, attorneys from its outside legal counsel Troutman Pepper Hamilton Sanders LLP, to modify or withdraw the acceleration request if necessary. The company has asked the SEC to confirm the Registration Statement's effective status with its legal representatives upon approval.
Avenue Therapeutics公司已正式向证券交易所委员会(SEC)请求加快其S-3表格的注册声明生效日期。总部位于佛罗里达州海湾群岛的公司于2024年5月8日通过EDGAR提交了请求,期望的生效日期为2024年5月10日美国东部时间下午4:00,或尽快生效。该请求是根据1933年修正的证券法规则461提出的。Avenue Therapeutics已授权其外部法律顾问Troutman Pepper Hamilton Sanders LLP的律师Rakesh Gopalan和David S.Wolpa在必要时修改或撤回加速请求。该公司已要求SEC在批准后通过其法律代表确认注册声明的有效状态。
Avenue Therapeutics公司已正式向证券交易所委员会(SEC)请求加快其S-3表格的注册声明生效日期。总部位于佛罗里达州海湾群岛的公司于2024年5月8日通过EDGAR提交了请求,期望的生效日期为2024年5月10日美国东部时间下午4:00,或尽快生效。该请求是根据1933年修正的证券法规则461提出的。Avenue Therapeutics已授权其外部法律顾问Troutman Pepper Hamilton Sanders LLP的律师Rakesh Gopalan和David S.Wolpa在必要时修改或撤回加速请求。该公司已要求SEC在批准后通过其法律代表确认注册声明的有效状态。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息